Medical and Clinical Science.

Real-time data. Real-time answers.

“Rivia empowers biotech medics by making it easy to review safety data alongside dosing and efficacy. Clinical leaders gain the ability to monitor data quality and trial progress with confidence.”

Jos Houbiers

CMO Calypso Biotech

For Medical Teams & Clinical Scientists

Study Start – Eligibility and Screening

  • Evaluate inclusion/exclusion criteria disposition by site, patient status, or user-defined clinical groupings.

  • Assess protocol deviations and root-causes for potential protocol adjustments.

  • Track and validate baseline data, such as biomarkers and disease activity, to confirm patient suitability and enhance PI collaboration.

Medical Monitoring

  • Transition from pooled overviews to patient-level data to evaluate signals and subgroup trends.

  • Correlate biomarkers, lab results, and clinical data to assess treatment impact and disease progression.

  • Monitor patient compliance by comparing visit schedules, IMP exposure adherence, and other recorded data.

  • Access real-time data updates to ensure compliance and maintain study quality.

Endpoint and Response Evaluation

  • Analyze treatment responses early by comparing clinical endpoints over time, as changes from baseline or multiples (e.g., iRECIST change from smallest, LFT as max ULN multiples) at population-level or by subgroup

  • Refine hypotheses by correlating clinical endpoints with baseline biomarkers, medical history, concomitant medications, and disease activity.

Key Advantages

Control and Clarity

View trial data from every necessary perspective for rapid, confident decisions.

Faster Decision-Making

Self-service analytics reduced dependency and streamlined reviews.

Adaptive Trial Design

Confident decisions to support flexible protocol adjustments.

Enhanced Collaboration

Up-to-date data foster clear, timely communication across teams.

Multiple sources.

One verdict.

Rivia streamlines our decision-making process by providing visualizations that can be easily understood by key stakeholders like the board. This aids in rapid response and adjustments in our strategic approach.

Blanky Tu

Head of Clinical Operations Oncology, Alentis Therapeutics

"I think every medic in the clinical trial, and also clinical leads in trials, should use this kind of software to have a better overview of their data."

Jos G.A. Houbiers

Chief Medical Officer, Calypso Biotech

"Without Rivia, we would be very dependent on our CRO and biostatisticians for almost every little detail of what we're analyzing, and we'd be spending a lot of time merging Excel spreadsheets."

Chris Farina

CEO, Abcentra Therapeutics

Explore How Rivia Solves

Real-World Challenges